Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals is a global pharmaceutical company. The Company is engaged in the development of new chemical entities (NCEs) and new biological entities (NBEs).

Pros:
Cons:
The company has delivered a poor growth of 10.44% over past five years.
Company might be capitalizing the interest cost

Peer Comparison Sector: Pharmaceuticals // Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Loading peers table ...

Quarterly Results Consolidated Figures in Rs. Crores / View Standalone

Sep 2016 Dec 2016 Mar 2017 Jun 2017 Sep 2017 Dec 2017 Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019
2,224 2,535 2,457 2,363 2,257 2,204 2,280 2,166 2,581 2,555 2,563 2,323
1,775 1,770 2,013 1,786 1,868 1,881 1,953 1,819 2,141 2,120 2,199 1,981
Operating Profit 449 765 444 577 388 323 327 347 440 435 364 342
OPM % 20% 30% 18% 24% 17% 15% 14% 16% 17% 17% 14% 15%
Other Income -2 15 -132 15 30 -23 70 138 307 -109 39 2
Interest 63 62 70 71 70 70 74 79 85 89 82 93
Depreciation 69 63 69 78 75 75 74 79 82 83 81 91
Profit before tax 315 655 173 444 273 154 248 327 580 154 240 160
Tax % 29% 27% -6% 25% 22% 32% 39% 29% 29% 24% 33% 32%
Net Profit 224 477 184 333 214 105 152 233 414 116 162 109
EPS in Rs 7.92 16.91 6.51 11.81 7.59 3.71 5.37 8.26 14.67 4.12 5.73 3.87
Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes Notes

Profit & Loss Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 TTM
1,934 2,040 2,412 2,949 4,021 5,012 6,005 6,563 7,562 9,079 9,074 9,865 10,023
1,131 1,702 1,792 2,357 3,306 3,997 4,914 5,348 6,125 7,045 7,457 8,280 8,442
Operating Profit 803 338 620 592 714 1,015 1,091 1,214 1,437 2,035 1,617 1,586 1,581
OPM % 42% 17% 26% 20% 18% 20% 18% 18% 19% 22% 18% 16% 16%
Other Income 51 179 50 144 18 11 11 -180 20 -42 89 375 239
Interest 71 146 166 160 147 160 189 190 179 237 286 335 349
Depreciation 72 103 121 95 98 127 217 300 234 264 302 326 337
Profit before tax 711 269 384 482 488 739 697 544 1,044 1,491 1,119 1,301 1,134
Tax % 11% 28% 14% 5% 5% 15% 22% 61% 29% 26% 28% 29%
Net Profit 632 192 324 453 460 620 542 210 743 1,109 804 925 801
EPS in Rs 25.30 7.58 11.96 16.70 17.02 22.89 19.99 7.31 26.33 39.29 28.49 32.78 28.39
Dividend Payout % 3% 5% 3% 2% 3% 0% 0% 26% 8% 5% 7% 6%
* Sales is net of excise duty and discounts
Compounded Sales Growth
10 Years:17.07%
5 Years:10.44%
3 Years:9.27%
TTM:12.54%
Compounded Profit Growth
10 Years:15.62%
5 Years:8.59%
3 Years:3.28%
TTM:13.91%
Stock Price CAGR
10 Years:1.81%
5 Years:-16.60%
3 Years:-32.34%
1 Year:-52.68%
Return on Equity
10 Years:19.82%
5 Years:19.55%
3 Years:19.47%
Last Year:15.20%

Balance Sheet Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
25 25 27 27 27 27 27 27 28 28 28 28
Reserves 1,493 1,573 2,328 2,010 2,375 2,736 2,956 1,756 3,601 4,464 5,135 5,577
Borrowings 991 2,094 1,869 2,108 2,244 2,765 3,267 3,800 3,988 4,724 4,639 4,449
437 565 659 952 1,237 1,643 2,383 2,895 2,785 2,790 3,201 3,607
Total Liabilities 2,946 4,257 4,884 5,098 5,883 7,171 8,634 8,479 10,403 12,006 13,004 13,661
919 1,566 1,787 2,034 2,223 2,822 3,091 2,015 2,594 2,755 3,030 3,670
CWIP 337 545 601 178 263 6 5 477 543 708 1,122 1,399
Investments 19 18 18 0 0 0 0 17 17 16 15 30
1,671 2,128 2,478 2,885 3,398 4,342 5,538 5,969 7,249 8,527 8,838 8,562
Total Assets 2,946 4,257 4,884 5,098 5,883 7,171 8,634 8,479 10,403 12,006 13,004 13,661

Cash Flows Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
372 16 352 931 804 648 854 482 345 657 1,648 1,324
-510 -950 -387 -404 -318 -558 -566 -712 -950 -1,001 -1,003 -883
189 849 70 -436 -361 195 -98 199 699 543 -468 -739
Net Cash Flow 51 -85 36 91 125 285 190 -31 93 199 177 -297

Ratios Consolidated Figures in Rs. Crores / View Standalone

Mar 2008 Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019
ROCE % 38% 13% 14% 15% 14% 18% 15% 16% 19% 21% 15% 15%
Debtor Days 152 171 163 140 113 119 131 140 120 97 94 81
Inventory Turnover 5.77 3.96 3.60 3.89 5.04 6.15 6.76 5.96 5.33 4.90 4.35 4.61

Recent Announcements

View all announcements

Annual Reports

Credit Ratings